Home Halogens 1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride

1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride

CAS No.:
129-74-8
Catalog Number:
AG007NAA
Molecular Formula:
C28H35Cl3N2
Molecular Weight:
505.9499
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
50mg
≥98%
1 week
United States
$91
- +
100mg
≥98%
1 week
United States
$119
- +
500mg
≥98%
1 week
United States
$283
- +
1g
≥98%
1 week
United States
$439
- +
Product Description
Catalog Number:
AG007NAA
Chemical Name:
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride
CAS Number:
129-74-8
Molecular Formula:
C28H35Cl3N2
Molecular Weight:
505.9499
MDL Number:
MFCD00242700
IUPAC Name:
1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride
InChI:
InChI=1S/C28H33ClN2.2ClH/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24;;/h4-16,27H,17-21H2,1-3H3;2*1H
InChI Key:
SDBHDSZKNVDKNU-UHFFFAOYSA-N
SMILES:
Clc1ccc(cc1)C(c1ccccc1)N1CCN(CC1)Cc1ccc(cc1)C(C)(C)C.Cl.Cl
EC Number:
204-962-4
Properties
Complexity:
514  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
504.187g/mol
Formal Charge:
0
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
505.952g/mol
Monoisotopic Mass:
504.187g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
6.5A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Why are most phospholipidosis inducers also hERG blockers? Archives of toxicology 20171201
High-performance column liquid chromatographic method for the simultaneous determination of buclizine, tryptophan, pyridoxine, and cyanocobalamin in tablets and oral suspension. Journal of AOAC International 20110101
Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC. Journal of chromatographic science 20100101
Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC. Pakistan journal of pharmaceutical sciences 20061001
Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 19950201
Properties